Robert A. Bradway - Mar 18, 2022 Form 4 Insider Report for AMGEN INC (AMGN)

Signature
/s/ Robert A. Bradway
Stock symbol
AMGN
Transactions as of
Mar 18, 2022
Transactions value $
-$4,123,069
Form type
4
Date filed
3/22/2022, 05:37 PM
Previous filing
Mar 3, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMGN Common Stock Tax liability -$4.12M -17.5K -2.77% $235.86 613K Mar 18, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include the following RSUs granted under the Company's equity plans: 4,790 RSUs which will vest on 4/27/2022; 10,580 RSUs which vest in installments of 5,211 on 5/3/2022 and 5,369 on 5/3/2023; 12,184 RSUs which vest in installments of 4,020 on 5/05/2022, 4,021 on 5/5/2023 and 4,143 on 5/5/2024; and 13,280 RSUs which vest in two installments of 4,382 on 4/30/2023 and 4/30/2024 and one installment of 4,516 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2 These shares include 2,773 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.